This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Surgery  • Surgical Physiology, Other  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

So What Do We Do Now?

Arch Intern Med. 2006;166:1342-1344.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Clinicians who see patients for primary care or for primary prevention of cardiovascular disease (CVD) are fortunate to have multivariable models^1-2 that can predict, with reasonable reliability, the absolute risk for future CVD events in large segments of the population.^3-4 Even in 2006, the absolute risk for future development of disease can be predicted for very few diseases, much less with the precision afforded by current CVD risk prediction models. These "risk scores" are a major advance over clinical risk prediction using relative risk estimates, and CVD prevention is one of the few areas in clinical practice to incorporate the use of absolute risk prediction into clinical practice guidelines.² However, it has been widely recognized that CVD risk prediction models are imperfect. Appropriately, many investigators are attempting to improve CVD risk prediction to refine our ability to estimate absolute risk and to find those individuals who appear to be at . . . [Full Text of this Article]

AUTHOR INFORMATION
Donald M. Lloyd-Jones, MD, ScM; Lu Tian, ScD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Newer Antiphospholipid Antibodies Predict Adverse Outcomes in Patients With Acute Coronary Syndrome
Greco et al.
Am J Clin Pathol 2009;132:613-620.
ABSTRACT | FULL TEXT  

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort
Simmons et al.
Diabetes Care 2009;32:708-713.
ABSTRACT | FULL TEXT  

Sudden Death After Myocardial Infarction
Adabag et al.
JAMA 2008;300:2022-2029.
ABSTRACT | FULL TEXT  

New cardiovascular risk determinants do exist and are clinically useful
Smulders et al.
Eur Heart J 2008;29:436-440.
ABSTRACT | FULL TEXT  

Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook
Circulation 2007;115:928-935.
ABSTRACT | FULL TEXT  

Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Young et al.
Diabetes Care 2006;29:2688-2693.
ABSTRACT | FULL TEXT  

Nontraditional CHD Risk Markers: How Much Value Do They Add?
Journal Watch Cardiology 2006;2006:1-1.
FULL TEXT  

C-Reactive Protein: Not Ready for Population-Wide CVD Risk Assessment
JWatch General 2006;2006:1-1.
FULL TEXT  

Cardiologists urge screening of asymptomatic older people
Charatan
BMJ 2006;333:168-168.
FULL TEXT